RxSight RXST
NASDAQ RXST
$6.33 -0.12 (-1.86%)
As of: Sep 9, 2026 · 3:59 PM EDT

RxSight (RXST) Other Non-Current Assets (2020 - 2026)

RxSight's (RXST) quarterly Other Non-Current Assets came in at $1.0 million in Q2 2026, up 36.53% on a YoY basis from $750000.0 in Q2 2025, and little changed quarter-over-quarter from $1.0 million in Q1 2026.

Analysis

RxSight (RXST) Other Non-Current Assets (2020 - 2026) Analysis & Trends

RxSight (RXST) has reported Other Non-Current Assets for 7 consecutive years, with $1.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Non-Current Assets rose 36.53% year-over-year to $1.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.0 million (up 36.53% YoY), and the FY2025 full-year result was $750000.0, changed 0.0% from the prior year.
  • Other Non-Current Assets was little changed at $1.0 million in Q2 2026 per RXST's latest filing, from $1.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $1.0 million in Q1 2026 and bottomed at $711000.0 in Q3 2023.
  • Historically, Other Non-Current Assets has averaged $781944.4 across 5 years, with a median of $750000.0 in 2024.
  • The widest YoY moves for Other Non-Current Assets: up 44.56% in 2022, down 39.66% in 2022.
  • Over 5 years, Other Non-Current Assets stood at $767000.0 in 2022, then slipped by 7.3% to $711000.0 in 2023, then rose by 5.49% to $750000.0 in 2024, then changed by 0.0% to $750000.0 in 2025, then soared by 36.53% to $1.0 million in 2026.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $1.0 million, $1.0 million, and $750000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn -
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn -
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 4.32 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 3.23 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 45.22 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 616.40 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 434.00 Mn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 273.70 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 215.10 Mn
10 RxSight 265.13 Mn -139.12 Mn - 1.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.02 Mn
Mar 31, 2026 1.03 Mn
Dec 31, 2025 750,000.00
Sep 30, 2025 748,000.00
Jun 30, 2025 750,000.00
Mar 31, 2025 750,000.00
Dec 31, 2024 750,000.00
Sep 30, 2024 711,000.00
Jun 30, 2024 711,000.00
Mar 31, 2024 711,000.00
Dec 31, 2023 711,000.00
Sep 30, 2023 711,000.00
Jun 30, 2023 761,000.00
Mar 31, 2023 761,000.00
Dec 31, 2022 767,000.00
Sep 30, 2022 811,000.00
Jun 30, 2022 811,000.00
Mar 31, 2022 811,000.00
Dec 31, 2021 811,000.00
Sep 30, 2021 561,000.00